Structures by: Bacher F.
Total: 41
C13H19N5OS
C13H19N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=22.7776(4)Å b=6.85850(10)Å c=9.8800(2)Å
α=90° β=98.889(2)° γ=90°
C18H20ClCuN5OS,CH4O
C18H20ClCuN5OS,CH4O
Journal of medicinal chemistry (2019) 62, 2 512-530
a=16.5043(12)Å b=17.7857(12)Å c=7.1311(6)Å
α=90° β=96.241(3)° γ=90°
C14H21N5OS
C14H21N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=6.1236(4)Å b=7.9500(6)Å c=30.956(2)Å
α=90° β=92.419(4)° γ=90°
3(C16H22ClCuN5O2S),1.75(CH4O)
3(C16H22ClCuN5O2S),1.75(CH4O)
Journal of medicinal chemistry (2019) 62, 2 512-530
a=22.2413(7)Å b=8.3324(2)Å c=31.9121(9)Å
α=90° β=90.5654(13)° γ=90°
C12H17N5OS
C12H17N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=11.544(3)Å b=13.204(3)Å c=10.086(3)Å
α=90° β=112.081(7)° γ=90°
3(C16H22ClCuN5OS),0.75(CH4O)
3(C16H22ClCuN5OS),0.75(CH4O)
Journal of medicinal chemistry (2019) 62, 2 512-530
a=24.702(4)Å b=9.1959(14)Å c=25.064(5)Å
α=90° β=100.971(6)° γ=90°
C18H21N5OS
C18H21N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=7.1287(2)Å b=15.0536(6)Å c=16.4704(6)Å
α=90° β=97.810(2)° γ=90°
C16H23N5O2S
C16H23N5O2S
Journal of medicinal chemistry (2019) 62, 2 512-530
a=13.3622(18)Å b=5.8899(6)Å c=21.414(3)Å
α=90° β=91.631(5)° γ=90°
C13H18ClCuN5OS
C13H18ClCuN5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=15.7566(11)Å b=14.2967(9)Å c=14.2703(10)Å
α=90° β=92.971(3)° γ=90°
(C12H18ClCuN5O2S),2(H2O)
(C12H18ClCuN5O2S),2(H2O)
Journal of medicinal chemistry (2019) 62, 2 512-530
a=9.2626(8)Å b=9.5087(8)Å c=11.0617(9)Å
α=89.565(2)° β=76.519(2)° γ=67.742(2)°
C12H16ClCuN5OS,C3H7NO
C12H16ClCuN5OS,C3H7NO
Journal of medicinal chemistry (2019) 62, 2 512-530
a=9.3959(3)Å b=19.8889(6)Å c=10.9744(3)Å
α=90° β=108.3661(7)° γ=90°
C23H18BrN5
C23H18BrN5
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10464-10478
a=18.405(4)Å b=8.2958(16)Å c=13.230(3)Å
α=90° β=103.962(8)° γ=90°
C23H18ClCuN5,C3H7NO
C23H18ClCuN5,C3H7NO
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10464-10478
a=10.3347(4)Å b=23.4454(7)Å c=11.0757(4)Å
α=90° β=117.7313(12)° γ=90°
C23H19Cl2CuN5,1.2(C3H7NO),0.25(H2O)
C23H19Cl2CuN5,1.2(C3H7NO),0.25(H2O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10464-10478
a=9.7602(13)Å b=13.4027(15)Å c=20.685(2)Å
α=98.235(4)° β=92.013(5)° γ=93.367(4)°
C23H18BrCl2CuN5,2(C3H7NO)
C23H18BrCl2CuN5,2(C3H7NO)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10464-10478
a=12.0530(9)Å b=16.7234(14)Å c=17.8152(15)Å
α=105.698(3)° β=105.962(3)° γ=106.665(3)°
C66H51Cl4Cu3N15,1.25(H2O),2(C3H7NO),2(Cl)
C66H51Cl4Cu3N15,1.25(H2O),2(C3H7NO),2(Cl)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10464-10478
a=13.0443(3)Å b=14.9957(3)Å c=20.2999(4)Å
α=92.0747(8)° β=103.4914(8)° γ=112.4054(8)°
C54H40Cu4N10O6,2(CF3O3S),2(C2H3N)
C54H40Cu4N10O6,2(CF3O3S),2(C2H3N)
New Journal of Chemistry (2020) 44, 39 16713-16720
a=22.949(5)Å b=11.893(2)Å c=22.443(5)Å
α=90° β=90.65(3)° γ=90°
C54H40Cu4N10O6,2(CF3O3S),2(C3H7NO)
C54H40Cu4N10O6,2(CF3O3S),2(C3H7NO)
New Journal of Chemistry (2020) 44, 39 16713-16720
a=22.475(5)Å b=12.394(3)Å c=22.723(5)Å
α=90° β=91.06(3)° γ=90°
C70H72Cu3N10O6,H2O
C70H72Cu3N10O6,H2O
New Journal of Chemistry (2020) 44, 39 16713-16720
a=14.798(3)Å b=15.401(3)Å c=16.328(3)Å
α=107.44(3)° β=116.00(3)° γ=91.19(3)°
C22H16BrCl2CuN5,0.55(CH4O)
C22H16BrCl2CuN5,0.55(CH4O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 28 10464-10478
a=37.232(3)Å b=11.3330(11)Å c=11.6674(10)Å
α=90° β=107.494(3)° γ=90°
C19H26ClN4O3PdS,Cl
C19H26ClN4O3PdS,Cl
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=6.9628(5)Å b=18.5602(13)Å c=17.4498(12)Å
α=90° β=101.011(2)° γ=90°
C19H26ClN4NiO3S,Cl
C19H26ClN4NiO3S,Cl
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=6.9292(2)Å b=18.4742(8)Å c=17.4103(7)Å
α=90° β=101.171(2)° γ=90°
4(C19H26N4O3S),5(CH4O)
4(C19H26N4O3S),5(CH4O)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=10.5018(4)Å b=24.7063(9)Å c=16.9193(7)Å
α=90° β=90.967(2)° γ=90°
C20H28Cl2CuN4O3S
C20H28Cl2CuN4O3S
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=20.3880(16)Å b=14.1122(7)Å c=15.9901(12)Å
α=90° β=100.503(6)° γ=90°
C13H19ClCuN6S,0.15(CH4O)
C13H19ClCuN6S,0.15(CH4O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=7.6944(5)Å b=17.4966(10)Å c=13.1409(8)Å
α=90.00° β=102.615(2)° γ=90.00°
C14H20ClCuN5OS,0.925(CH4O)
C14H20ClCuN5OS,0.925(CH4O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=9.8676(7)Å b=12.0982(8)Å c=16.6060(10)Å
α=86.450(3)° β=74.015(3)° γ=77.176(3)°
C17H21ClCuN6O3S
C17H21ClCuN6O3S
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=8.0848(4)Å b=12.1277(6)Å c=12.3563(5)Å
α=63.8664(17)° β=83.4075(18)° γ=73.0771(17)°
C15H24ClCuN6S,Cl,2(H2O)
C15H24ClCuN6S,Cl,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=7.6629(3)Å b=11.7864(3)Å c=13.0949(4)Å
α=72.1141(11)° β=73.6132(12)° γ=74.3107(11)°
2(C12H16ClCuN5OS),C4H10O
2(C12H16ClCuN5OS),C4H10O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=7.7969(6)Å b=17.4139(14)Å c=13.1450(10)Å
α=90.00° β=103.700(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C31H28Cl2N5Ru,Cl
Organometallics (2011) 30, 2 273-283
a=26.5354(10)Å b=26.5354(10)Å c=9.0872(4)Å
α=90.00° β=90.00° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- osmium(II)} chloride hydrate
C33H33ClN5Os,0.5(O2),Cl
Organometallics (2011) 30, 2 273-283
a=11.690(2)Å b=21.276(4)Å c=25.898(4)Å
α=90.00° β=102.712(9)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- osmium(II)} chloride diethyl ether water solvate
4(C31H28Cl2N5Os),2(C2H5O2),O3,4(Cl)
Organometallics (2011) 30, 2 273-283
a=17.2834(5)Å b=14.0348(5)Å c=29.4680(11)Å
α=90.00° β=106.416(4)° γ=90.00°
{(hapto^6^-p-cymene)[N-(5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride hydrate
C32H31ClN5Ru,0.2(O4),Cl,0.9(O)
Organometallics (2011) 30, 2 273-283
a=10.4899(3)Å b=11.8881(3)Å c=25.1390(8)Å
α=90.00° β=95.195(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C34H36.4Cl2N5O0.7Ru
Organometallics (2011) 30, 2 273-283
a=10.6834(11)Å b=12.0598(12)Å c=25.482(3)Å
α=90.00° β=93.080(7)° γ=90.00°
C13H15CuN5O2S,2(H2O)
C13H15CuN5O2S,2(H2O)
Inorganic Chemistry (2013) 52, 8895-8908
a=7.49000(10)Å b=10.00060(10)Å c=21.5284(3)Å
α=90.00° β=90.00° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride ethanol solvate
C32H30Cl2N5Ru,C2H6O,Cl
Organometallics (2011) 30, 2 273-283
a=10.7350(4)Å b=12.0515(4)Å c=25.1678(9)Å
α=90.00° β=94.293(2)° γ=90.00°
C26H30N10Ni2O4S2,4(CH4O)
C26H30N10Ni2O4S2,4(CH4O)
Inorganic chemistry (2014) 141112160101001
a=13.2489(4)Å b=15.2821(5)Å c=17.9458(7)Å
α=90.00° β=90.00° γ=90.00°
C15H19CuN5O2S,H2O
C15H19CuN5O2S,H2O
Inorganic chemistry (2014) 141112160101001
a=6.6987(7)Å b=13.3713(18)Å c=18.755(2)Å
α=90.00° β=90.00° γ=90.00°
C13H15N5O2SZn,CH4O
C13H15N5O2SZn,CH4O
Inorganic chemistry (2014) 141112160101001
a=8.2454(4)Å b=11.8012(6)Å c=16.8293(7)Å
α=90.00° β=93.338(3)° γ=90.00°
C26H30N10Ni2O4S2,3.25(CH4O)
C26H30N10Ni2O4S2,3.25(CH4O)
Inorganic chemistry (2014) 141112160101001
a=13.1049(7)Å b=15.1240(13)Å c=18.0808(16)Å
α=90.00° β=90.00° γ=90.00°
C30H38N10Ni2O4S2,5.75(CH4O)
C30H38N10Ni2O4S2,5.75(CH4O)
Inorganic chemistry (2014) 141112160101001
a=11.7885(13)Å b=11.8487(13)Å c=55.473(6)Å
α=90.00° β=90.00° γ=90.00°